In memoriam: Jeffrey Cameron
Jeffrey Cameron, an associate professor of biochemistry at the University of Colorado Boulder, passed away on September 25 at the age of 43 in Colorado. He made seminal contributions to understanding microbe cellular processes.

Born on February 16, 1981, in La Grange, Illinois, Cameron studied plant science at Montana State University and Washington University, where he obtained his Ph.D. and completed his postdoctoral training.
In 2015, he opened his lab at CU Boulder, which focused on understanding the physiology, cell biology and biochemistry of the photosynthetic microbe, cyanobacteria. His research on cellular signaling and metabolic regulation in cyanobacteria aimed to harness their carbon-fixing mechanisms to combat climate change, leading to innovations like bacteria-grown biomaterials that reduce emissions from traditional cement production. In 2016, Cameron cofounded the biotech company Prometheus Materials, which uses microalgae to create zero-carbon bio-cement and bio-concrete.
Cameron was also a mentor and educator. Many of his students and colleagues remember him for his brilliance as well as his kindness. He was deeply committed to fostering a collaborative research environment and was known for his generosity in sharing knowledge.
Outside of the lab, Cameron enjoyed cooking, hiking and mushroom hunting.
He is survived by his wife, Jennifer Michelle Cameron, and four children, Noelle Rose, Jasper Carlyle, Evette Blue and Margot Love. He is also survived by his parents, three siblings and three grandparents.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.